Prescription Drug Monitoring Act of 2024

This bill requires states receiving federal drug monitoring funds to implement mandatory prescription drug monitoring programs (PDMPs). It directly affects healthcare providers (like doctors and pharmacists) in covered states, mandating they check the PDMP before prescribing certain controlled substances (schedules II-IV) and every 3 months during treatment. Key provisions include requiring pharmacies to report prescriptions within 24 hours, PDMPs to alert providers about misuse patterns, and states to share quarterly de-identified data with the public and researchers. States failing to comply risk losing federal grant funding for their PDMPs.